NME7 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.715600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.390800E-01
Normal-vs-Stage2
4.797600E-01
Normal-vs-Stage3
8.771000E-01
Normal-vs-Stage4
2.257000E-01
Stage1-vs-Stage2
5.377800E-01
Stage1-vs-Stage3
5.389600E-01
Stage1-vs-Stage4
2.087000E-01
Stage2-vs-Stage3
2.938200E-01
Stage2-vs-Stage4
4.416300E-02
Stage3-vs-Stage4
1.382580E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.910600E-01
Normal-vs-AfricanAmerican
2.323800E-01
Normal-vs-Asian
6.977600E-01
Caucasian-vs-AfricanAmerican
2.379200E-01
Caucasian-vs-Asian
5.051400E-01
AfricanAmerican-vs-Asian
1.057790E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.299200E-01
Normal-vs-Female
5.235200E-01
Male-vs-Female
2.102400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.700800E-01
Normal-vs-Age(41-60Yrs)
2.891000E-01
Normal-vs-Age(61-80Yrs)
6.031200E-01
Normal-vs-Age(81-100Yrs)
4.609400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.018000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.348600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.564200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.276180E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.675000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.936800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.356000E-01
Normal-vs-Daily Drinker
8.037200E-01
Normal-vs-Weekly Drinker
5.362000E-01
Normal-vs-Occasional Drinker
3.388600E-01
Normal-vs-Social Drinker
5.264000E-01
Non Drinker-vs-Daily Drinker
7.018400E-01
Non Drinker-vs-Weekly Drinker
8.949000E-01
Non Drinker-vs-Occasional Drinker
1.024170E-01
Non Drinker-vs-Social Drinker
6.701800E-01
Daily Drinker-vs-Weekly Drinker
6.563400E-01
Daily Drinker-vs-Occasional Drinker
7.656000E-02
Daily Drinker-vs-Social Drinker
4.965600E-01
Weekly Drinker-vs-Occasional Drinker
1.254160E-01
Weekly Drinker-vs-Social Drinker
7.766800E-01
Occasional Drinker-vs-Social Drinker
2.014000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.305600E-01
Normal-vs-Grade 2
1.439230E-01
Normal-vs-Grade 3
1.309230E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.325700E-02
Grade 1-vs-Grade 3
3.644400E-02
Grade 1-vs-Grade 4
2.305600E-01
Grade 2-vs-Grade 3
5.323400E-01
Grade 2-vs-Grade 4
1.439230E-01
Grade 3-vs-Grade 4
1.309230E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.422600E-01
Normal-vs-NonDiabetic
4.601600E-01
Diabetic-vs-NonDiabetic
3.259800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.665800E-01
Normal-vs-NoPancreatitis
4.949000E-01
Pancreatitis-vs-NoPancreatitis
5.003400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.054400E-01
Normal-vs-N1
4.999200E-01
N0-vs-N1
5.453000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.886370E-01
Normal-vs-TP53-NonMutant
4.223200E-01
TP53-Mutant-vs-TP53-NonMutant
1.284490E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
